Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Oliver R. Baumann
Alexander Zink
Carl von Halem
Board:
Norbert Windhab
Désirée Dosch
Mark Müller
David Deck
Shareholding in %:
Akira Holding AG 6.96
Baader Bank AG (Investment Management) 0.75
BlackRock Asset Management Deutschland AG 0.13
Gilbert Schoeni 19.69
Monega Kapitalanlagegesellschaft mbH 0.78
Pictet Asset Management SA 0.1
UBS Asset Management Switzerland AG 1.19
Vartex International LLC 22.86
Zürcher Kantonalbank (Investment Management) 0.38
amandea Vermögensverwaltung AG 0.07
Freefloat 47.09
Address: Talacker 35, 8001 Zürich
T: +41-44-385-84-60
F: +
I: http://www.xlifesciences.ch
E: info@xlifesciences.ch